申请人:Banyu Pharmaceutical Co., Ltd.
公开号:US03935221A1
公开(公告)日:1976-01-27
Halo-fusaric acid amides having the formula ##SPC1## Wherein X represents halogen or hydrogen, Y represents halogen and R.sub.1 and R.sub.2 are same or different and represent hydrogen or a lower alkyl group (C.sub.1-4) which are characterized by significant activity in the treatment of hypertension.
具有以下式子的Halo-富沙酸酰胺##SPC1##
其中X代表卤素或氢,Y代表卤素,R.sub.1和R.sub.2相同或不同,代表氢或较低的烷基(C.sub.1-4),其特征在于在治疗高血压方面具有显著的活性。